JP2006507355A5 - - Google Patents

Download PDF

Info

Publication number
JP2006507355A5
JP2006507355A5 JP2004571738A JP2004571738A JP2006507355A5 JP 2006507355 A5 JP2006507355 A5 JP 2006507355A5 JP 2004571738 A JP2004571738 A JP 2004571738A JP 2004571738 A JP2004571738 A JP 2004571738A JP 2006507355 A5 JP2006507355 A5 JP 2006507355A5
Authority
JP
Japan
Prior art keywords
alkyl
mono
alkoxycarbonyl
alkoxy
group
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
JP2004571738A
Other languages
English (en)
Japanese (ja)
Other versions
JP2006507355A (ja
JP4708034B2 (ja
Filing date
Publication date
Priority claimed from GB0220962A external-priority patent/GB0220962D0/en
Priority claimed from GB0315870A external-priority patent/GB2392910A/en
Application filed filed Critical
Priority claimed from PCT/EP2003/009525 external-priority patent/WO2004024700A1/en
Publication of JP2006507355A publication Critical patent/JP2006507355A/ja
Publication of JP2006507355A5 publication Critical patent/JP2006507355A5/ja
Application granted granted Critical
Publication of JP4708034B2 publication Critical patent/JP4708034B2/ja
Anticipated expiration legal-status Critical
Expired - Fee Related legal-status Critical Current

Links

JP2004571738A 2002-09-10 2003-08-28 急性および慢性炎症、虚血およびリモデリング過程に対する治療剤としてのピリミジノン誘導体 Expired - Fee Related JP4708034B2 (ja)

Applications Claiming Priority (7)

Application Number Priority Date Filing Date Title
GB0220962A GB0220962D0 (en) 2002-09-10 2002-09-10 Heterocyclic derivatives
GB0220962.5 2002-09-10
GB0226609A GB0226609D0 (en) 2002-09-10 2002-11-14 Heterocyclic derivatives
GB0226609.6 2002-11-14
GB0315870A GB2392910A (en) 2002-09-10 2003-07-07 2-Oxopyrimidine derivatives and their use as human leukocyte elastase inhibitors
GB0315870.6 2003-07-07
PCT/EP2003/009525 WO2004024700A1 (en) 2002-09-10 2003-08-28 Pyrimidinone derivatives as therapeutic agents against acute and chronic inflammatory, ischaemic and remodelling processes

Publications (3)

Publication Number Publication Date
JP2006507355A JP2006507355A (ja) 2006-03-02
JP2006507355A5 true JP2006507355A5 (US07794700-20100914-C00152.png) 2009-09-10
JP4708034B2 JP4708034B2 (ja) 2011-06-22

Family

ID=39827677

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2004571738A Expired - Fee Related JP4708034B2 (ja) 2002-09-10 2003-08-28 急性および慢性炎症、虚血およびリモデリング過程に対する治療剤としてのピリミジノン誘導体

Country Status (9)

Country Link
JP (1) JP4708034B2 (US07794700-20100914-C00152.png)
AR (1) AR042179A1 (US07794700-20100914-C00152.png)
EC (1) ECSP055669A (US07794700-20100914-C00152.png)
ES (1) ES2414865T3 (US07794700-20100914-C00152.png)
GB (1) GB2392910A (US07794700-20100914-C00152.png)
HK (1) HK1088304A1 (US07794700-20100914-C00152.png)
PE (1) PE20041078A1 (US07794700-20100914-C00152.png)
TW (1) TWI314555B (US07794700-20100914-C00152.png)
UA (1) UA82074C2 (US07794700-20100914-C00152.png)

Cited By (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US7915347B2 (en) 2002-09-26 2011-03-29 L'oreal S.A. Block polymers and cosmetic compositions and processes comprising them
US8710152B2 (en) 2006-07-27 2014-04-29 L'oreal Block polymers and their process of preparation
US8992903B2 (en) 2002-09-26 2015-03-31 L'oreal Composition comprising at least one block polymer and at least one gelling agent

Families Citing this family (22)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
SE0302486D0 (sv) 2003-09-18 2003-09-18 Astrazeneca Ab Novel compounds
FR2860143B1 (fr) 2003-09-26 2008-06-27 Oreal Composition cosmetique comprenant un polymere sequence et une huile siliconee non volatile
ES2428503T3 (es) * 2004-02-26 2013-11-08 Bayer Intellectual Property Gmbh 1,4-Diaril-dihidropirimidin-2-onas y su uso como inhibidores de elastasa de neutrófilos humanos
CA2557271C (en) * 2004-02-26 2012-08-21 Bayer Healthcare Ag 1,4-diaryl-dihydropyrimidin-2-ones and their use as human neutrophil elastase inhibitors
TW200808771A (en) 2006-05-08 2008-02-16 Astrazeneca Ab Novel compounds II
TW200808763A (en) 2006-05-08 2008-02-16 Astrazeneca Ab Novel compounds I
US20110003858A1 (en) * 2006-09-04 2011-01-06 Bergstroem Lena Multimeric heterocyclic compounds useful as neutrophil elastase inhibitors
MX2010004673A (es) 2007-11-06 2010-05-27 Astrazeneca Ab Algunos derivados de 2-pirazinona y su uso como inhibidores de elastasa de los neutrofilos.
BRPI0821027B8 (pt) * 2007-12-20 2021-05-25 Bayer Ip Gmbh 4-(4-ciano-2-tioaril)di-hidropirimidinonas para tratamento e/ou prevenção de lesões do pulmão e do sistema cardiovascular, seu processo de preparação e seu uso, e medicamento
DE102008022521A1 (de) * 2008-05-07 2009-11-12 Bayer Schering Pharma Aktiengesellschaft 1,4-Diaryl-pyrimidopyridazin-2,5-dione und ihre Verwendung
US8642595B2 (en) * 2008-06-09 2014-02-04 Bayer Intellectual Property Gmbh Annellated 4-(indazolyl)-1,4-dihydropyridine derivatives and methods of use thereof
TW201036957A (en) 2009-02-20 2010-10-16 Astrazeneca Ab Novel salt 628
DE102009016553A1 (de) * 2009-04-06 2010-10-07 Bayer Schering Pharma Aktiengesellschaft Sulfonamid- und Sulfoximin-substituierte Diaryldihydropyrimidinone und ihre Verwendung
WO2011039528A1 (en) 2009-10-02 2011-04-07 Astrazeneca Ab 2-pyridone compounds used as inhibitors of neutrophil elastase
US20140221335A1 (en) 2013-02-06 2014-08-07 Boehringer Ingelheim International Gmbh Substituted bicyclic dihydropyrimidinones and their use as inhibitors of neutrophil elastase activity
US9115093B2 (en) 2013-03-04 2015-08-25 Boehringer Ingelheim International Gmbh Substituted bicyclic dihydropyrimidinones and their use as inhibitors of neutrophil elastase activity
USRE47493E1 (en) 2014-02-20 2019-07-09 Boehringer Ingelheim International Gmbh Substituted bicyclic dihydropyrimidinones and their use as inhibitors of neutrophil elastase activity
US9440930B2 (en) * 2014-07-31 2016-09-13 Boehringer Ingelheim International Gmbh Substituted bicyclic dihydropyrimidinones and their use as inhibitors of neutrophil elastase activity
US9458113B2 (en) 2014-07-31 2016-10-04 Boehringer Ingelheim International Gmbh Substituted bicyclic dihydropyrimidinones and their use as inhibitors of neutrophil elastase activity
US9290457B2 (en) 2014-07-31 2016-03-22 Boehringer Ingelheim International Gmbh Substituted dihydropyrimidinones and their use as inhibitors of neutrophil elastase activity
US9657015B2 (en) 2014-07-31 2017-05-23 Boehringer Ingelheim International Gmbh Substituted bicyclic dihydropyrimidinones and their use as inhibitors of neutrophil elastase activity
US9475779B2 (en) 2014-07-31 2016-10-25 Boehringer Ingelheim International Gmbh Substituted bicyclic dihydropyrimidinones and their use as inhibitors of neutrophil elastase activity

Cited By (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US7915347B2 (en) 2002-09-26 2011-03-29 L'oreal S.A. Block polymers and cosmetic compositions and processes comprising them
US7932324B2 (en) 2002-09-26 2011-04-26 L'oreal Block polymers and cosmetic compositions and processes comprising them
US8992903B2 (en) 2002-09-26 2015-03-31 L'oreal Composition comprising at least one block polymer and at least one gelling agent
US8710152B2 (en) 2006-07-27 2014-04-29 L'oreal Block polymers and their process of preparation

Similar Documents

Publication Publication Date Title
JP2006507355A5 (US07794700-20100914-C00152.png)
JP2007524696A5 (US07794700-20100914-C00152.png)
JP2020521740A5 (US07794700-20100914-C00152.png)
JP2011509309A5 (US07794700-20100914-C00152.png)
JP2010501478A5 (US07794700-20100914-C00152.png)
JP2008510828A5 (US07794700-20100914-C00152.png)
JP2007517035A5 (US07794700-20100914-C00152.png)
JP2017525757A5 (US07794700-20100914-C00152.png)
JP2014503574A5 (US07794700-20100914-C00152.png)
JP2007517044A5 (US07794700-20100914-C00152.png)
JP2009515988A5 (US07794700-20100914-C00152.png)
CA2668997A1 (en) 4-cyanophenylamino-substituted bicyclic heterocyclic compounds as hiv inhibitors
JP2004516314A5 (US07794700-20100914-C00152.png)
JP2005535586A5 (US07794700-20100914-C00152.png)
JP2009536620A5 (US07794700-20100914-C00152.png)
JP2005526857A5 (US07794700-20100914-C00152.png)
JP2010520869A5 (US07794700-20100914-C00152.png)
JP2004535447A5 (US07794700-20100914-C00152.png)
RU2004126671A (ru) Гетероарилсоединения, полезные в качестве ингибиторов gsk-3
CA2498051A1 (en) Pyrimidinone derivatives as therapeutic agents against acute and chronic inflammatory, ischaemic and remodelling processes
JP2007532628A5 (US07794700-20100914-C00152.png)
JP2011509302A5 (US07794700-20100914-C00152.png)
JP2020521767A5 (US07794700-20100914-C00152.png)
RU2007116987A (ru) Новые соединения
JP2007502295A5 (US07794700-20100914-C00152.png)